Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Succinylcholine
Drug ID BADD_D02079
Description Succinylcholine is a depolarizing skeletal muscle relaxant consisting of two molecules of the endogenous neurotransmitter [acetylcholine] (ACh) linked by their acetyl groups.[A19054] It has been widely used for over 50 years,[A299] most commonly in its chloride salt form, as a means of neuromuscular blockade during intubation and surgical procedures. Its rapid onset and offset, with effects beginning within 60 seconds of intravenous administration and lasting between four to six minutes, make succinylcholine particularly useful in the setting of short medical procedures requiring brief periods of muscle relaxation.[L9004]
Indications and Usage Succinylcholine is indicated as an adjunct to general anesthesia, to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation.[L9004]
Marketing Status approved
ATC Code M03AB01
DrugBank ID DB00202
KEGG ID D00766
MeSH ID D013390
PubChem ID 5314
TTD Drug ID D0Q7ZQ
NDC Product Code 43598-666; 71872-7241
UNII J2R869A8YF
Synonyms Succinylcholine | Succinyldicholine | Suxamethonium | Dicholine Succinate | Succinate, Dicholine | Quelicin | Succinylcholine Dichloride | Dichloride, Succinylcholine | Succinylcholine Dichloride, Di-H2O | Succinylcholine Dichloride, Di H2O | Succinylcholine Diiodide | Diiodide, Succinylcholine | Myorelaxin | Succinylcholine Diperchlorate | Diperchlorate, Succinylcholine | Succinylcholine Iodide | Suxamethonium Bromide | Bromide, Suxamethonium | Suxamethonium Chloride | Listenon | Succinylcholine Chloride | Anectine | Celocurine | Ditilin | Lysthenon | Succicuran | Succinylcholine Dibromide | Dibromide, Succinylcholine
Chemical Information
Molecular Formula C14H30N2O4+2
CAS Registry Number 306-40-1
SMILES C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Pulseless electrical activity02.03.04.0200.000057%-
Myoglobinaemia02.04.02.028; 15.05.03.028---
Neurological symptom17.02.05.010---
Porphyrin metabolism disorder03.08.01.006; 09.01.10.004; 14.14.01.006---
Pulmonary function test decreased13.19.01.001---
Increased bronchial secretion22.12.01.002---
Acute kidney injury20.01.03.016--
Therapeutic product effect decreased08.06.01.0500.000251%-
Therapeutic product effect delayed08.06.01.0510.000194%-
Therapeutic product effect prolonged08.06.01.0540.000268%-
Therapy non-responder08.06.01.0630.000125%-
The 3th Page    First    Pre   3    Total 3 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene